Production (Stage)
Lisata Therapeutics, Inc.
LSTA
$2.69
$0.041.51%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 8.20% | 7.34% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.71% | 11.49% | |||
| Operating Income | -18.15% | 7.25% | |||
| Income Before Tax | -23.34% | 6.49% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2.47% | 6.49% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.47% | 6.49% | |||
| EBIT | -18.15% | 7.25% | |||
| EBITDA | -18.26% | 7.29% | |||
| EPS Basic | -0.02% | 7.32% | |||
| Normalized Basic EPS | -15.36% | 3.29% | |||
| EPS Diluted | -0.02% | 7.32% | |||
| Normalized Diluted EPS | -15.36% | 3.29% | |||
| Average Basic Shares Outstanding | 2.47% | 0.89% | |||
| Average Diluted Shares Outstanding | 2.47% | 0.89% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||